JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged)
WKN A2PR30 | ISIN LU2053353665 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0208607159 | Pictet - Biotech - P dy USD | +81,02 % | +22,09 % | 3,57 |
|
| 2 | IE00BF23BV98 | Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | +83,96 % | +24,59 % | 3,32 |
|
| 3 | IE00B42Z4531 | Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | +83,59 % | +24,60 % | 3,31 |
|
| 4 | LU0320646986 | Pictet - Biotech - P dy GBP | +76,60 % | +22,52 % | 3,30 |
|
| 5 | IE00B3XLHR60 | Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares | +82,69 % | +24,59 % | 3,27 |
|
| 13 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +42,60 % | +20,88 % | 1,93 |
|
| 14 | AT0000746748 | ERSTE STOCK BIOTEC EUR R01 (A) | +40,42 % | +20,07 % | 1,90 |
|
| 15 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | +38,24 % | +20,64 % | 1,75 |
|
| 16 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | +38,09 % | +20,64 % | 1,74 |
|
| 17 | DE0008481862 | Allianz Biotechnologie - A - EUR | +36,90 % | +20,64 % | 1,68 |
|